Screen. Prevent. Treat. For Colorectal Cancer Management

March 21, 2019

Upcoming/Recent Talks

Screen. Prevent. Treat. For Colorectal Cancer Management

with Dr. Jimmy J. Hwang

March 25, 2019, 3 PM EST

RSVP

March is National Colorectal Cancer Awareness Month. According to the American Cancer Society, there will be more than 100,000 new cases of colon cancer and more than 44,000 rectal cancer cases diagnosed in 2019. Colorectal cancer may cause over 50,000 deaths this year. However, 90% of colorectal cancers are preventable, but one out of three people who should be screened, aren't doing it! We are talking to Dr. Jimmy J. Hwang, from Levine Cancer Institute to understand colorectal cancer screening, prevention and treatment options. The discussion would touch upon identifying high risk groups who should opt for screening, available screening techniques, prevention of onset and treatment options, and guidance for efficient management of colorectal cancer.

Panelists

Dr. Jimmy J. Hwang

Johnny Nelson

Amy Marsh

Priya Menon

February 20th, 2019, 3 PM EST

LISTEN

Eating disorders (ED) are serious and sometimes fatal illnesses that cause the sufferers to become obsessed with food, body weight and shape, and severely disturb their eating behaviour. Common eating disorders include binge eating disorder, bulimia nervosa, and anorexia nervosa. Recent research around the neurobiology of eating disorders has changed the way we address nourishing ED patients during treatment. Where we once thought of food as a symptom, and only important to prevent death by starvation, we now understand the critical importance of early intervention and full weight restoration. These recommendations challenge old paradigms about the cause and meaning of ED symptoms. This talk with Dr Angela Guarda of Johns Hopkins Hospital, Dr Jennifer Gaudiani and nutritionist Therese Waterhous draws out the role of nourishment from the perspectives of someone with lived experience as well as leading clinicians in the medical and nutritional treatment of these dangerous brain disorders.

Panelists

Dr. Angela Guarda

Dr. Jennifer Gaudiani

Therese Waterhous

Laura Collins Lyster-Mensh

Tabitha Farrar

Shweta Mishra

February 14, 2019, 11 AM EST

LISTEN

Dr. David Fajgenbaum was diagnosed with a rare disorder that killed 35% of patients within five years of diagnosis. Dr. Fajgenbaum realised that he would have to lead the charge against his rare condition and we are talking to this young doctor about his incredible journey unraveling Castleman Disease. Castleman Disease is a rare disease of lymph nodes and related tissues. This is diagnosed in about 5000 people of all ages each year in the United States. This disorder activates the body's immune system, releasing excess inflammatory proteins that can shut down the liver, kidneys and bone marrow. Dr. David Fajgenbaum, Founding Director of the Castleman Disease Center at the University of Pennsylvania discusses the current understanding of the disease that he himself has had nearly for nine years, symptoms, treatment options and explore new trials and research that are in the offing.

Panelists